TITLE

A REVIEW OF RECENT FEDERAL LEGISLATIVE AND POLICY INITIATIVES TO ENHANCE THE DEVELOPMENT AND EVALUATION OF HIGH VALUE DRUGS IN THE UNITED STATES

AUTHOR(S)
Neyarapally, George A.
PUB. DATE
March 2013
SOURCE
DePaul Journal of Health Care Law;Spring2013, Vol. 14 Issue 3, p503
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers information on federal legislative and government policy initiatives for the developments and evaluation of high value drugs in the U.S. Topics include legislative initiatives under the U.S. Food and Drug Administration's (FDA) Safety and Innovation Act, American Recovery and Reinvestment Act (ARRA) funding for federal comparative effectiveness research, and Patient Protection and Affordable Care Act (PPACA) for medication therapy Management.
ACCESSION #
93380582

 

Related Articles

  • Recent Expansions in Fraud Provisions. M. T. // Trustee;Feb2011, Vol. 64 Issue 2, p20 

    The article enumerates different acts that were passed for fraud provision in the U.S. The American Recovery and Reinvestment Act of 2009 expands the protection and incentive of whistle-blowers. The Fraud Enforcement and Recovery Act of 2009, meanwhile, expands the False Claims Act liability and...

  • Draft Guidance for Industry on Compliance Policy for Reporting Drug Sample Distribution Information; Availability. Kux, Leslie // Federal Register (National Archives & Records Service, Office of;4/3/2012, Vol. 77 Issue 64, p20025 

    The article offers information on a notice issued by the U.S. Food and Drug Administration to inform about the availability of a draft guidance related to the procedures and regulations for reporting the drug sample transparency and distribution. The draft has been prepared in accordance with...

  • Patient Safeguards Needed for Biosimilar Development.  // Chicago Citizen - Chatham Southeast Edition;10/22/2014, Vol. 49 Issue 31, p16 

    The article focuses on the efforts of licensing for medications known as "biosimilars," similar to cutting-edge biologic medicines under the provision of the U.S. Patient Protection and Affordable Care Act. It mentions that the U.S. Food and Drug Administration (FDA), accepted the first...

  • Beyond the EHR. Ingari, Frank // Health Management Technology;Jan2013, Vol. 34 Issue 1, p20 

    The article discusses technology factors and trends that are expected to drive health care improvement. It mentions technology mandates that the industry must comply with following the upholding of the Affordable Care Act of 2010 by the U.S. Supreme Court. The role of electronic health record...

  • Federal investments help ease growing shortages.  // AHA News;10/24/2011, Vol. 47 Issue 21, p8 

    The article reports on the increase of clinicians in the U.S. National Health Service Corps (NHSC) as the result of the 2010 Patient Protection and Affordable Care Act and the 2009 American Recovery and Reinvestment Act.

  • The Effects of the State of Tennessee Immunization Policy Change of 2011 - 2012 on Vaccination Uptake in East Tennessee. Knight, Margaret A.; Kershenbaum, Anne D.; Buchanan, Martha; Ridley, Janet; Erwin, Paul C. // Frontiers in Public Health Services & Systems Research;Mar2014, Vol. 3 Issue 1, preceding p1 

    In the United States, funding for the purchase of vaccines depend on annual Congressional allocations. These allocations fluctuate from year to year as Congress responds to changes in national needs for immunizations. The Affordable Care Act requires first dollar coverage of immunizations and...

  • Austerity takes a toll. Thomas, John D. // Modern Healthcare;7/8/2013, Vol. 43 Issue 27, p17 

    An interview with Doctor Sanjay Basu, an epidemiologist and co-author of the book "The Body Economic: Why Austerity Kills," is presented. Basu offers his view on the admission by the International Monetary Fund (IMF) that its austerity plans have possibly harmed Greece and other countries. He...

  • Incubators boost IT startups. Conn, Joseph // Modern Healthcare;2/3/2014, Vol. 44 Issue 5, p10 

    The article discusses emergence of health information technology (IT)incubators in the U.S. Topics discussed include DocTimeLog software being developed by Chicago-based Ludi Inc., incubator Healthbox run by entrepreneur Gail Peace, facilities provided by incubators for new companies such as...

  • EDITOR'S PAGE. A Discombobulating Reversal of Dynamics--or an Opportunity? Hagland, Mark // Healthcare Informatics;Jul/Aug2013, Vol. 30 Issue 5, p6 

    The author discusses the need for practicing physicians to develop clinical computing. The author states that physician workflow optimization serves as the key factor in improving cost-effectiveness, healthcare quality, and patient-centeredness of medical care delivery. The author adds that the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics